JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM
Clinical trial NCT04208464 · COMPLETED
Trial details
- NCT number
- NCT04208464
- Sponsor
- University of Manchester
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-07
- Primary completion
- 2023-09-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.